The evolution of modern medicine, in its continuous developing process, is highly connected with the progress achieved in the medical branch of technology. Regarding the surgical specialties, the technological progress breakthroughs may determine the appearance of new diagnosis techniques, but also shape innovative treatments, leading to superior therapeutic results. In the surgical treatment as a whole, an essential role is played by the Medical Imagistics. They either offer the much-needed visual support in order to reach an accurate diagnosis, or guide the surgeon in choosing a certain type of intervention. The importance of Imagistics is indisputable. It has also been proven so in intraoperatory guidance and monitoring the patient in post-surgery. In the evolution of medical Imagistics, after the transition to digital imaging, followed by graphic 3D reconstructions based on CT and MRI data, we find ourselves contemporary with a new turning point announcing a technological revolution: the transition from virtual 3D models to tangible 3D replica. Since the beginning, the 3D printing technology has been of great importance to the field of medical research and, once the technique gained popularity, it became a modern tool for many medical specialties, in particular for cranio-maxillofacial surgery, orthopedics, oncology, neurosurgery. The 3D printing technology managed to transgress dated barriers by facilitating the manufacturing of implants or implement new treatments in regenerative medicine. The purpose of this original paper is to present our 3D printing work protocol and general conclusions after 5 years of implementing 3D printing in pediatric orthopedics.
The purpose of this paper is to evaluate the postoperative results in paediatric patients with osteoid osteoma. We present a retrospective study including 16 patients under 18 years old treated surgically in our institution between April 2019 and September 2020. Patient demographic data, clinical aspects and imaging studies used to establish the diagnosis, lesion location, the size of the nidus, surgical data, hospitalization periods, complications and particular conditions were noted.Sixteen patients with mean age of 11.19 years (between 5 and 17 years) were treated using surgical excision (open or minimal invasive) or radiofrequency ablation (RFA). All patients presented with night pain highly responsive to nonsteroidal anti-inflammatory drugs. Imaging studies before surgery included radiographs, CT scans and/or MRI, technetium-99 bone scans. Interval between symptoms onset and surgery varied from 3 to 18 months (mean 8.18 months). Eight patients were treated using radiofrequency ablation under fluoroscopy, 5 cases were treated using minimal invasive surgery (resection-biopsy with trocar) and 3 cases were treated by open surgical excision. We have obtained histopathologic diagnosis in all cases. One patient had a superficial wound infection and two patients presented recurrent pain. In 13 patients the pain disappeared during the first 48 hours after surgery. Mean follow-up time was 10.12 months.RFA is the treatment of choice in paediatric cases of osteoid osteoma. Vicinity of important anatomical structure are contraindications for RFA. Using ablation probes with cooled tips may result in more predictable outcomes. The tendency to use less and less invasive procedures in the surgical fields seems to lead to development of non-invasive procedure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.